Why Value-Based Health Care Is Here To Stay
Necessity Is The Mother Of Invention
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.
You may also be interested in...
Smart use of healthcare technology improves care delivery, saves time, increases productivity and can improve staff morale. At some point in the usage cycle, savings will start to be made, although when this happens – and whether it should be the prime reason for the adoption of IT-based healthcare delivery solutions – is open to debate. What is clear is that a modern approach is vital if state-provided healthcare, as we know it, is to remain sustainable in the long term. The private and public sectors both have key roles to play, says Ashley Yeo, at the second annual HETTExpo
The Swedish liquid biopsy start-up expects to be the first company to secure US FDA approval for a metabolism-based urine test for the early detection of kidney cancer in post-surgery patients.
Singapore Prepares UDI System, Malaysia Seeks Regulatory Improvements And Indonesia Adjusts To Changing Environment
Medtech industry representatives from ASEANMed member economies, notably Singapore, Malaysia and Indonesia, provided regulatory updates at the February Asia Regulatory Roundtable. These roundtables are organized by the ARQon consultancy and the Asia Regulatory Professional Association (ARPA). They are sponsored by Medtech Insight.